Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Hemophilia B, F9 Gene, Full Gene Next-Generation Sequencing Mayo Clinic Laboratories Mayo Clinic United States | 3 | 1 |
|
Factor IX (F9) Gene Sequencing with duplication/deletion (NGS, MLPA) (2 Day STAT TAT) Machaon Diagnostics United States | 1 | 1 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Hemophilia B, Factor IX Gene Mutation Screening Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Invitae United States | 24 | 8 |
|
F9 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 164 |
|
Machaon Diagnostics United States | 6 | 3 |
|
Genome-Nilou Lab Iran | 110 | 146 |
|
Hemophilia B, 306900, X-linked recessive; HEMB (Hemophilia B) (Prenatal) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Hemophilia B, 306900, X-linked recessive; HEMB (Hemophilia B) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae United States | 409 | 164 |
|
Invitae United States | 208 | 81 |
|
Invitae United States | 224 | 112 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Hemophilia B: Carrier analysis with intragenic markers (Hhal, Ddel, Taq1) Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.